SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Abgenix, Inc. (ABGX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mopgcw who wrote (230)6/13/2003 10:58:31 AM
From: JFitnich  Read Replies (1) of 590
 
I wish I shared Ms. Malloy's view that AMGN would be "aggressive". Amgen no longer acts like a biotech.

With Immunex, you had Wall St. pressure to come up with another product to complement Enbrel. IMNX would have driven hard IMO (and disclosed results rapidly).

I sold half my ABGX holdings. I still have faith, but saw the need to take some $$ off the table while the pot is bubbling.

JF

BTW - mopgcw - Thanks for your posts of the GS research. The info is appreciated.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News